Estrogenpräparate

Estrogenpräparate are pharmaceutical preparations containing estrogen, a group of steroid hormones. They are primarily used in hormone replacement therapy (HRT) to alleviate symptoms associated with estrogen deficiency, most commonly menopausal symptoms such as hot flashes, vaginal dryness, and mood changes. These preparations can also be prescribed for other conditions including osteoporosis prevention, certain types of cancer treatment, and in gender-affirming care.

Estrogenpräparate are available in various forms, including oral tablets, transdermal patches, gels, sprays, vaginal creams, and pessaries. The choice of preparation and dosage depends on the individual's medical history, specific needs, and the intended therapeutic goal. They can be administered alone or in combination with progestogens, particularly in women with a uterus, to reduce the risk of endometrial hyperplasia and cancer.

The use of estrogenpräparate carries potential benefits and risks. Benefits include relief from menopausal symptoms and prevention of bone loss. However, potential risks include an increased risk of blood clots, stroke, certain types of cancer (breast, endometrial), and gallbladder disease. The decision to use estrogenpräparate should be made in consultation with a healthcare professional who can assess individual risk factors and benefits. Regular medical follow-up is recommended for individuals using these medications.